Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy

Journal of the American College of Cardiology

Volumn 63, Issue 2, 2014, Pages 141-149

  Fallavollita, James A ^a,b   Heavey, Brendan M ^b   Luisi Jr , Andrew J ^b   Michalek, Suzanne M ^b   Baldwa, Sunil ^a,b   Mashtare Jr , Terry L ^c   Hutson, Alan D ^c   Dekemp, Robert A ^e   Haka, Michael S ^b   Sajjad, Munawwar ^b   Cimato, Thomas R ^b   Curtis, Anne B ^b   Cain, Michael E ^b,d   Canty Jr , John M ^a,b,d  

^a VA Western New York Health Care System   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d University at Buffalo The State University of New York   (United States)

^e UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

11C meta hydroxyephedrine; myocardial viability; positron emission tomography; sudden cardiac arrest; sympathetic denervation

Indexed keywords

ANGIOTENSIN; CREATININE; AMMONIA N 13; FLUORODEOXYGLUCOSE F 18; METAHYDROXYEPHEDRINE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; HEART DENERVATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; SYMPATHETIC INNERVATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CLINICAL TRIAL; ECHOCARDIOGRAPH; FOLLOW UP; HEART INFARCTION SIZE; HEART INNERVATION; HIGH RISK PATIENT; MALE; PATIENT IDENTIFICATION; PET SCANNER; PREDICTION; RISK ASSESSMENT; RISK FACTOR;

(11)C-HED; (11)C-META-HYDROXYEPHEDRINE; (123)I-META-IODOBENZYLGUANIDINE; (18)F-2-DEOXYGLUCOSE; (18)FDG; B-TYPE NATRIURETIC PEPTIDE; BNP; ICD; IMPLANTABLE CARDIAC DEFIBRILLATOR; LEFT VENTRICLE; LEFT VENTRICULAR EJECTION FRACTION; LV; LVEF; MAGNETIC RESONANCE IMAGING; MIBG; MRI; MYOCARDIAL VIABILITY; PET; POSITRON EMISSION TOMOGRAPHY; SCA; SUDDEN CARDIAC ARREST; SYMPATHETIC DENERVATION; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA; VF; VT;

AGED; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MYOCARDIAL ISCHEMIA; POSITRON-EMISSION TOMOGRAPHY; PRIMARY PREVENTION; PROSPECTIVE STUDIES; SURVIVAL RATE; SYMPATHECTOMY; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 84892415494     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.07.096     Document Type: Article

References (30)

1. R. Passman, and J.J. Goldberger Predicting the future: risk stratification for sudden cardiac death in patients with left ventricular dysfunction Circulation 125 2012 3031 3037
2. P. Lorvidhaya, K. Addo, A. Chodosh, V. Iyer, J. Lum, and A.E. Buxton Sudden cardiac death risk stratification in patients with heart failure Heart Fail Clin 7 2011 157 174 vii
3. A.J. Moss, W.J. Hall, and D.S. Cannom et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1996 1933 1940
4. A.J. Moss, W. Zareba, and W.J. Hall et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
5. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
6. H.V. Huikuri, A. Castellanos, and R.J. Myerburg Sudden death due to cardiac arrhythmias N Engl J Med 345 2001 1473 1482
7. G.F. Tomaselli, and D.P. Zipes What causes sudden death in heart failure? Circ Res 95 2004 754 763
8. I. Matsunari, U. Schricke, and F.M. Bengel et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes Circulation 101 2000 2579 2585
9. J.A. Fallavollita, and J.M. Canty Jr. Dysinnervated but viable myocardium in ischemic heart disease J Nucl Cardiol 17 2010 1107 1115
10. J.M. Canty Jr., G. Suzuki, M.D. Banas, F. Verheyen, M. Borgers, and J.A. Fallavollita Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death Circ Res 94 2004 1142 1149
11. 11C-hydroxyephedrine retention in hibernating myocardium: Chronic inhomogeneity of sympathetic innervation in the absence of infarction J Nucl Med 46 2005 1368 1374
12. J.A. Fallavollita, A.J. Luisi Jr., and S.M. Michalek et al. Prediction of arrhythmic events with positron emission tomography: PAREPET study design and methods Contemp Clin Trials 27 2006 374 388
13. J.A. Fallavollita, A.J. Luisi Jr., E. Yun, R.A. Dekemp, and J.M. Canty Jr. An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy J Nucl Cardiol 17 2010 637 645
14. R.S. Beanlands, T.D. Ruddy, and R.A. deKemp et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function J Am Coll Cardiol 40 2002 1735 1743
15. 82Rb PET J Nucl Med 41 2000 1426 1435
16. K.C. Allman, D.M. Wieland, O. Muzik, T.R. DeGrado, E.R. Wolfe Jr., and M. Schwaiger Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans J Am Coll Cardiol 22 1993 368 375
17. J.P. Daubert, D.J. Wilber, and A. Lin et al. ICD therapy for fast ventricular tachycardia or ventricular fibrillation is a surrogate endpoint for mortality in MADIT II (abstr) Circulation 108 2003 IV385
18. A.J. Moss, H. Greenberg, and R.B. Case et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator Circulation 110 2004 3760 3765
19. A.E. Buxton, K.L. Lee, and L. DiCarlo et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 342 2000 1937 1945
20. L.E. Hinkle Jr., and H.T. Thaler Clinical classification of cardiac deaths Circulation 65 1982 457 464
21. M.J. Boogers, C.J. Borleffs, and M.M. Henneman et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients J Am Coll Cardiol 55 2010 2769 2777
22. S.D. Roes, C.J. Borleffs, and R.J. van der Geest et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator Circ Cardiovasc Imaging 2 2009 183 190
23. I. Klem, J.W. Weinsaft, and T.D. Bahnson et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation J Am Coll Cardiol 60 2012 408 420
24. J.S. Perkiomaki, P.E. Bloch Thomsen, A.M. Kiviniemi, M.D. Messier, and H.V. Huikuri Risk factors of self-terminating and perpetuating ventricular tachyarrhythmias in post-infarction patients with moderately depressed left ventricular function, a CARISMA sub-analysis Europace 13 2011 1604 1611
25. P. Merlet, H. Valette, and J.L. Dubois-Rande et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 1992 471 477
26. S. Tamaki, T. Yamada, and Y. Okuyama et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion J Am Coll Cardiol 53 2009 426 435
27. A.F. Jacobson, R. Senior, and M.D. Cerqueira et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure J Am Coll Cardiol 55 2010 2212 2221
28. J.P. Piccini, J.R. Horton, and L.K. Shaw et al. Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death Circ Cardiovasc Imaging 1 2008 180 188
29. S. de Haan, T.A. Meijers, P. Knaapen, A.M. Beek, A.C. van Rossum, and C.P. Allaart Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models Heart 97 2011 1951 1956
30. F.M. Bengel, and M. Schwaiger Assessment of cardiac sympathetic neuronal function using PET imaging J Nucl Cardiol 11 2004 603 616